Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2006
10/25/2006EP1713905A1 Protein with activity of hydrolyzing amylopectin, starch, glycogen and amylose, gene encoding the same, cell expressing the same, and production method thereof
10/25/2006EP1713904A1 Production and purification of recombinant arylsulfatase a
10/25/2006EP1713825A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
10/25/2006EP1713348A1 Stabilized phosphatase formulations
10/25/2006EP1713347A1 Stabilized enzyme formulations
10/25/2006EP1546368A4 Analytical method for the determination of infant formula protein digestibility in vitro
10/25/2006EP1507869A4 Improved receptor detection
10/25/2006EP1501925A4 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
10/25/2006EP1235805B1 Immunoassay for neonicotinyl insecticides
10/25/2006EP0977876B1 Nucleic acid molecules from artichoke (cynara scolymus) encoding enzymes having fructosyl polymerase activity
10/25/2006EP0719339B1 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis
10/25/2006CN1852986A Production of polyunsaturated fatty acids in oleaginous yeasts
10/25/2006CN1852984A A non-denaturing process to purify recombinant proteins from plants
10/25/2006CN1852975A Transgenic high tryptophan plants
10/25/2006CN1852765A Compositions for separating molecules
10/25/2006CN1852736A Immunoglobulin chimeric monomer-dimer hybrids
10/25/2006CN1850976A Glucose kinase derivant for inhibiting platelet aggregation and thrombase activity, and its preparing method
10/25/2006CN1281746C Biological polysaccharide high molecular micro ball fixnig beta-galactosidase and its prearing method
10/25/2006CN1281744C Maltose-trehalose converting enzyme, and preparation and uses thereof
10/25/2006CN1281743C Preparation method of earthworm kinase dry powder
10/25/2006CN1281742C Polycondensed amino-acid coordinated SOD simulatives
10/25/2006CN1281737C Producing basic proteinase by vibrio metschnikovii DL 33-51 strain
10/25/2006CN1281735C Low-temperature proteinase, and its production method and special bacterial strain
10/25/2006CN1281733C Penicillium capable of giving high yield of alpha-alactosidase as well as its application for preparing feeding alpha-alactosidase in solid state fermentation
10/25/2006CN1281732C Production of agar-agar enzyme by Alteromonas sp.nov.SY 37-12 strain
10/25/2006CN1281624C Thrombin derivatives and its process for production
10/24/2006US7126044 Plant genes conferring resistance to Citrus tristeza virus
10/24/2006US7126039 Animal tissue with carbohydrate antigens compatible for human transplantation
10/24/2006US7125984 For degradation by fucoidan deacetylases, glucuronidases, and fucosidases
10/24/2006US7125982 Microbial production of nuclease resistant DNA, RNA, and oligo mixtures
10/24/2006US7125979 Upstream control elements of the proopiomelanocortin gene and their use
10/24/2006US7125977 Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
10/24/2006US7125971 Full-length genomic RNA of papaya leaf-distortion mosaic virus
10/24/2006US7125960 crosslinked elastin having elasticity suitable for transplantation into the body while avoiding detachment of the coated cell adhesion proteins such as collagen or laminin
10/24/2006US7125956 Peptide fragment of interleukin 1 beta converting enzyme (ICE) itself as ICE inhibitors; peptide is linked to an agent capable of specifically directing the compound to a cell such as fragment of Antennepedia polypeptide, an antibody, an adjuvant or a cell-specific ligand; neurodegenerative disorders
10/24/2006US7125955 mitotic kinase, NIMA, encoded by the Aspergillus nimA gene; pure WW domain of a Pin1 polypeptide which interacts with NIMA; a Peptidyl-prolyl cis/trans isomerases (PPIase); drug target; Pin1 is a PPIase known to be essential for life
10/24/2006US7125841 Mutants and heparin for blood disorders
10/24/2006US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006US7125715 Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production
10/24/2006US7125707 Using crystalline cell surface protein for directed monomolecular bonding of molecular layers and/or their attachment to solid support; immobilized cells; micelles
10/24/2006US7125704 Heat resistant, storage stable, and capable of dehydrating D-gluconic acid to produce 2-keto-3-deoxy-D-gluconic acid; particularly derived from Achromobacter xylosoxidans
10/24/2006US7125703 Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
10/24/2006US7125702 Preparation of an proteolytic enzymatic hydrolysate of a selected soybean storage protein fraction, glycinin, that evidences potent Angiotensin Converting Enzyme inhibitory activity.
10/24/2006US7125701 Aggrecanase molecules
10/24/2006US7125700 Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
10/24/2006US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006US7125698 Polynucleotides isolated from Lactobacillus rhamnosus, oligonucleotide probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, organisms incorporating them
10/24/2006US7125697 Expression vector containing the polynucleotide; cell transformation; use in diganostics and as substrate for luminescent reactions; coelenterazine
10/24/2006US7125695 Generating bacterial strain with reversible mutation in gene/s associated with DNA repair; bioreactors and heterologous gene expression
10/24/2006US7125693 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives
10/24/2006US7125689 Method for rendering streptokinase less immunogenic to a human
10/24/2006US7125684 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
10/24/2006US7125682 Methods for measuring protein kinase and phosphatase activity
10/24/2006US7125677 NIMA interacting proteins
10/24/2006US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator
10/24/2006US7125672 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
10/24/2006US7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
10/24/2006US7125662 Identifying microorganismal nucleotide sequences associated with antibiotic resistance protein for use as components to improve identification of vector transformed cells
10/24/2006US7125569 Removal of plasmin(ogen) from protein solutions
10/24/2006US7125550 Play a role in capacitation of sperm and the fertilization of the ovum and make ideal targets for the design of contraceptive agents.
10/24/2006US7125548 Nucleotide sequences coding microorganismal cistron; for use in detection of microoganismal infection
10/21/2006CA2541986A1 Carbonic anhydrase having increased stability under high temperatue conditions
10/19/2006WO2006110508A2 Plants with increased phosphorous uptake
10/19/2006WO2006110188A2 Genes conferring herbicide resistance
10/19/2006WO2006110164A2 Deactivation of linking moieties in antibody-enzyme conjugates
10/19/2006WO2006110083A1 A host cell comprising a vector for production of proteins requiring gamma-carboxylation
10/19/2006WO2006109675A1 Antitumor agent and novel dnase
10/19/2006WO2006109632A1 NOVEL α-KETO ACID TRANSFERASE, GENE FOR THE SAME, AND USE OF THE SAME
10/19/2006WO2006109578A1 Altered pyrroloquinoline-quinone-dependent glucose dehydrogenase and method of improving substrate specificity of pyrroloquinoline-quinone-dependent glucose dehydrogenase
10/19/2006WO2006109198A2 Methods for obtaining optically active glycidyl ethers and optically active vicinal diols from racemic substrates
10/19/2006WO2006108905A1 In vitro cancer therapy compound identification method
10/19/2006WO2006108525A1 Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebrates
10/19/2006WO2006108273A1 Identification of a beta-1,3-n-acetylgalactosaminyltransferase (cgte) from campylobacter jejuni lio87
10/19/2006WO2006074194A3 Engineered phosphite dehydrogenase mutants for nicotinamide cofactor regeneration
10/19/2006WO2006068170A9 Method for improvement of heat stability of glucose dehydrogenase
10/19/2006WO2006065139A3 Deacylation of lps in gram negative bacteria
10/19/2006WO2006065126A3 Terpene hydroxylation
10/19/2006WO2006040313A3 Mutant expandases
10/19/2006WO2006008294A3 Diagnostic and therapeutic use of slim3 for neurodegenerative diseases
10/19/2006WO2006007560A3 Targeted protein replacement for the treatment of lysosomal storage disorders
10/19/2006WO2004074302A3 Autosomal recessive polycystic kidney disease nucleic acids and peptides
10/19/2006WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2006US20060236434 Methods and compositions for tobacco plants with reduced nicotine
10/19/2006US20060236433 Nicotiana hybrids and plant varieties for use in production of pharmaceuticals
10/19/2006US20060236431 Gene encoding protein involved in cytokinin synthesis
10/19/2006US20060236430 Methods and compositions for producing male sterile plants
10/19/2006US20060236428 Manipulation of cellulose and/or beta-1,4-glucan
10/19/2006US20060236426 Nucleic acid molecules encoding starch degrading enzymes
10/19/2006US20060236425 Plant acyltransferases
10/19/2006US20060236414 Proteases and methods for producing them
10/19/2006US20060236410 Protein specific for cardiac and skeletal muscle
10/19/2006US20060235203 MN gene and protein
10/19/2006US20060234942 Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements
10/19/2006US20060234935 Mutants of the factor VII epidermal growth factor domain
10/19/2006US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006US20060234912 Methods for modulating neuronal responses
10/19/2006US20060234367 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance
10/19/2006US20060234366 Crosslinked enzyme aggregates
10/19/2006US20060234365 Methods of purification of cytochrome P450 proteins
10/19/2006US20060234364 Genetically modified yeast species and fermenation processes using genetically modified yeast